Botulinum toxin: yesterday, today, tomorrow
Botulinum toxin (BoNT) is a bacterial neurotoxin presented with seven serotypes that inhibit neurotransmitter release from nerve endings. The serotypes of BoNT are antigenically dissimilar, act via different, but interconnected mechanisms, and are not interchangeable. The activity of BoNT is associa...
Main Authors: | A. R. Artemenko, A. L. Kurenkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-02-01
|
Series: | Нервно-мышечные болезни |
Subjects: | |
Online Access: | https://nmb.abvpress.ru/jour/article/view/44 |
Similar Items
-
The preparations of Botulinum toxin type A in the treatment of lower limb post-stroke spasticity. Clinical observation
by: V. K. Misikov
Published: (2015-02-01) -
Pharmacoepidemiology of botulinum toxin in the complex therapy of post-stroke spasticity in the Russian Federation. The survey data of neurologists
by: Kolbin A. S., et al.
Published: (2018-06-01) -
Botulinum toxin type A chemodenervation treatment in spastic forms of cerebral palsy
by: A. L. Kurenkov, et al.
Published: (2015-02-01) -
Neurotoxic denervation of the left atrium for atrial fibrillation treatment and prevention: an experimental animal study
by: А. Г. Стрельников, et al.
Published: (2015-10-01) -
Botulinum toxin treatment of lower extremity spasticity
by: S. E. Khat’kova, et al.
Published: (2017-11-01)